Articles written by: Dennis Silva

Comparison of Fidus Investment Corporation (FDUS) and Nuveen Short Duration Credit Opportunities Fund (NYSE:JSD)

This is therefore a comparing of the risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation in Fidus Investment Corporation (NASDAQ:FDUS) and Nuveen Short Duration Credit Opportunities Fund (NYSE:JSD). The two are both Asset Management companies that compete with one another. Valuation & Earnings Gross Revenue Price/Sales Ratio Net […]

Comparison of Opiant Pharmaceuticals Inc. (OPNT) and Tyme Technologies Inc. (NASDAQ:TYME)

Opiant Pharmaceuticals Inc. (NASDAQ:OPNT) and Tyme Technologies Inc. (NASDAQ:TYME) are two firms in the Biotechnology that compete against each other. Below is a comparison of their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio […]

Comparing of uniQure N.V. (QURE) and Dare Bioscience Inc. (NASDAQ:DARE)

As Biotechnology businesses, uniQure N.V. (NASDAQ:QURE) and Dare Bioscience Inc. (NASDAQ:DARE), are affected by compare. This especially applies to their risk, analyst recommendations, institutional ownership, profitability, dividends, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio uniQure N.V. 53 0.00 31.26M -2.73 […]

Contrasting of Stereotaxis Inc. (STXS) and AtriCure Inc. (NASDAQ:ATRC)

Stereotaxis Inc. (NYSEAMERICAN:STXS) and AtriCure Inc. (NASDAQ:ATRC) are two firms in the Medical Instruments & Supplies that compete against each other. Below is a comparison of their dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings […]

Reviewing Galera Therapeutics Inc. (GRTX)’s and Audentes Therapeutics Inc. (NASDAQ:BOLD)’s results

Galera Therapeutics Inc. (NASDAQ:GRTX) and Audentes Therapeutics Inc. (NASDAQ:BOLD), both competing one another are Biotechnology companies. We will contrast their analyst recommendations, institutional ownership, profitability, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Galera Therapeutics Inc. 12 0.00 N/A […]

Comparison of PLx Pharma Inc. (PLXP) and Vital Therapies Inc. (:)

This is therefore a contrasting of the dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation in PLx Pharma Inc. (NASDAQ:PLXP) and Vital Therapies Inc. (:). The two are both Biotechnology companies that compete with one another. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Reviewing Gilead Sciences Inc. (GILD)’s and Zafgen Inc. (NASDAQ:ZFGN)’s results

Gilead Sciences Inc. (NASDAQ:GILD) and Zafgen Inc. (NASDAQ:ZFGN) compete against each other in the Biotechnology sector. We will compare them and contrast their analyst recommendations, profitability, institutional ownership, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Gilead Sciences Inc. […]

Comparing of BioXcel Therapeutics Inc. (BTAI) and Aldeyra Therapeutics Inc. (NASDAQ:ALDX)

BioXcel Therapeutics Inc. (NASDAQ:BTAI) and Aldeyra Therapeutics Inc. (NASDAQ:ALDX) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as risk, analyst recommendations, profitability, dividends, institutional ownership, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income […]